Clinical Trials for BlueRock Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: BlueRock Therapeutics

Clinical Trials (4)

NCT06944522
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
PHASE3Recruiting
102 participants
Started: Jun 17, 2025 · Completed: Mar 31, 2032
1 condition2 sponsors10 locations
NCT06789445
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
PHASE1/PHASE2Recruiting
54 participants
Started: Mar 10, 2025 · Completed: Oct 31, 2030
9 conditions1 sponsor3 locations
NCT05897957
Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01
N/AEnrolling by invitation
12 participants
Started: May 16, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor3 locations
NCT05363046
Noninterventional Study Evaluating Parkinson's Disease Diary Use
N/AActive, not recruiting
194 participants
Started: Jul 29, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor34 locations